RTI Surgical Inc.
RTI Surgical (Nasdaq: RTIX) is a leading global surgical implant company providing surgeons with biologic, metal and synthetic implants. Committed to advancing science, safety and innovation, RTI’s implants are used in sports medicine, general surgery, spine, orthopedic, trauma and cardiothoracic procedures. They are distributed in more than 47 countries. Water Street partnered with RTI’s board of directors in 2013 to support the company with acquiring Pioneer Surgical Technology. The acquisition transformed RTI into a global leader offering one of the industry’s most comprehensive portfolios of biologic implants. We are continuing to work with the board to pursue strategies that will further increase RTI’s long-term value.
CEOWork with us
Camille Farhat joined RTI Surgical as chief executive officer on March 15, 2017. He is a seasoned executive with a recognized track record of transforming, revitalizing and profitably growing businesses globally. His experience is built from extensive work experience across multiple companies in 10 countries and nine industries over the course of his professional career. Camille has gained broad experience in the healthcare industry globally spanning pharmaceuticals, implantable devices, capital equipment, consumables and services. Prior to joining RTI, Camille was president and CEO of American Medical Systems (AMS), the world leader in medical devices and procedures that treat pelvic health conditions, which was sold to Boston Scientific. Prior to AMS, he advanced several business segments for Baxter International, serving as global general manager of Baxter Pharmaceuticals & Technologies and global general manager of Global Infusion Systems. Prior to Baxter, he was vice president of business development at Medtronic, and previously, global general manager of the company’s gastroenterology and urology divisions. Earlier in his career, Camille gained broad executive and leadership experience during his 13 years at General Electric. He has served on the board of directors of ADVAMED and the Advanced Medical Technology Association. He currently serves on the board of directors of Cardiac Science, the LAU Health Foundation and is a member of Northwestern Memorial Cerebrovascular Neurosurgery Advisory Council. Camille earned a master of business administration from Harvard University, a degree in European Union Studies from Institut National d’Etudes Politiques de Paris. and graduated summa cum laude from Northeastern University with a bachelor’s degree in international finance and accounting.